|
Volumn 13, Issue 4, 2005, Pages 1059-1067
|
Understanding topoisomerase I and II in terms of QSAR
|
Author keywords
Hydrophobicity; Molar refractivity; Molar volume; NVE; QSAR; Topoisomerase inhibitor
|
Indexed keywords
1,4 NAPHTHOQUINONE DERIVATIVE;
ANTINEOPLASTIC AGENT;
ARACHIDIC ACID;
BENZIMIDAZOLE DERIVATIVE;
CAMPTOTHECIN DERIVATIVE;
CIS FATTY ACID;
DNA TOPOISOMERASE;
DNA TOPOISOMERASE (ATP HYDROLYSING);
EICOSADIENOIC ACID;
ETOPOSIDE;
FUSED HETEROCYCLIC RINGS;
ICOSAPENTAENOIC ACID;
ICOSATETRAENOIC ACID;
ICOSATRIENOIC ACID;
LINOLEIC ACID;
OLEIC ACID;
QUINOLONE DERIVATIVE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
DRUG MECHANISM;
DRUG STRUCTURE;
ENZYME INHIBITION;
PHYSICAL CHEMISTRY;
QUANTITATIVE STRUCTURE ACTIVITY RELATION;
DNA TOPOISOMERASES, TYPE I;
DNA TOPOISOMERASES, TYPE II;
ENZYME INHIBITORS;
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 12844278089
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2004.11.033 Document Type: Article |
Times cited : (42)
|
References (29)
|